Sundar Pichai announces 'exciting milestone' as Google AI partners with Yale to discover new cancer therapy route

On Wednesday, Alphabet CEO Sundar Pichai shared an “exciting milestone” achieved by DeepMind’s Gemma. The AI ​​model, in a research collaboration with Yale University, has developed a new path for potential cancer therapy. In a post on X, Google’s CEO announced that the tech giant has developed a new cancer therapy hypothesis. “An exciting milestone for AI in science: Our C2S-scale 27B foundation model, built with @Yale and based on Gemma, generated a new hypothesis about cancer cellular behavior, which scientists experimentally validated in living cells,” he wrote. “With more preclinical and clinical testing, this discovery could reveal a promising new path for developing therapies to fight cancer,” Pichai added. (This is a developing story. Check back for updates)